We
make funds available for Leukemia Research. There
are thousands of charities where you can choose to send your hard earneddollars.
The WES Foundation recognizes that choice exists and,
that to deserve your consideration, the dollars you contribute must be
distributed in the most judicious fashion to ultimately fund the research
necessary to find a cure. Here’s how that is accomplished.
The When Everyone Survives Foundation has selected an Advisory Board of medical professionals to determine the most productive research recipients. These research professionals provide an invaluable service to the foundation by judging the requests we receive and choosing the most innovative, responsible and financially judicious research recipients for funding.
In May of 2007, the When Everyone Survives Foundation Advisory Board chose the first recipients for research grants from the foundation. They are Dr. Meir Wetzler of Roswell Park Cancer Center in Buffalo, NY and Dr. Jian-Ming Li of Emory University’s Winship Cancer Center in Atlanta. To find out more, click on the WeSearch tab for descriptions of their biographies, proposals and research institutions.
The
WES Foundation intends to be different.
Technically, charities need only to distribute about 15% of the proceeds
collected to charitable causes to be considered a bona fide charity.
In fact, the goal of the When Everyone Survives Foundation is to spend
less than 20% on the administrative cost of the fund, with the balance,
a full 80%, either going directly to research or into the endowment of
the Foundation to build critical mass and earn interest for distribution
of future research grants. To keep administrative costs down to that
level, it will be necessary to either collect large amounts of contributions
each year or develop the endowment to a size that supports the normal
cost of operation and still provides more dollars for research. By establishing
an endowment, the interest earned provides continuing income for funding
research and will, in time, allow the Foundation to make substantial
contributions in that regard. The WES Foundation 
was started with a rather
generous contribution to that endowment. The establishment of the endowment
at such an early date in the formation of the foundation provides management
the opportunity to properly diversify the investments of the endowment
for the highest overall return balanced against the lowest relative risk.
With that assurance, you can have the comfort of knowing that your contribution
will benefit leukemia research for years to come.
|
